Kimberly Janvier-Withrow
Obstetrics & Gynecology · Davie, FLNPI 1336680545
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $884 and has fallen 53.6% since, to $410 in 2025.
Across 134 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$418
- Mayne Pharma Commercial LLC$416
- Bayer$315
- Astellas Pharma US Inc$229
- Hologic Sales And Service, LLC$212
- Myovant Sciences Inc.$172
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $418 |
| Mayne Pharma Commercial LLC | 28 | $416 |
| Bayer | 10 | $315 |
| Astellas Pharma US Inc | 8 | $229 |
| Hologic Sales And Service, LLC | 9 | $212 |
| Myovant Sciences Inc. | 6 | $172 |
| Evofem Biosciences, Inc. | 7 | $152 |
| Johnson & Johnson | 3 | $114 |
| Exact Sciences | 6 | $112 |
| Daiichi Sankyo Inc. | 4 | $96 |
| Exeltis, USA Inc. | 5 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Organon | 3 | $62 |
| Therapeuticsmd, Inc. | 3 | $57 |
| Millicent US Inc | 2 | $43 |
| Coopersurgical, Inc. | 2 | $41 |
| Biogen | 2 | $37 |
| Pfizer | 2 | $34 |
| Biotissue Holdings Inc. | 2 | $33 |
| Kerecis Limited | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Scynexis, Inc. | 1 | $25 |
| Medtronic | 1 | $23 |
| Organogenesis Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$106
How this compares
$2,861 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Davie
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.